Panflux Otc 20 mg Gastro-resistant tablets
PDF Leaflet Revision Date: 22 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term relief of heartburn and hyperacidity.
Dosage (summary)
20 mg once daily for a maximum of 14 days; no adjustment for elderly or mild to moderate renal impairment.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Increased digoxin availability
- Reduced absorption of azole antifungals
- Increased PT/INR with warfarin
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Co-administration with atazanavir
Common side effects
- Headache
- Dizziness
- Gastrointestinal complaints
Counselling Points
- Take before or during breakfast
- Consult doctor if no relief in 2 weeks
- Monitor for persistent gastrointestinal symptoms
Serious warnings
- Risk of Clostridium difficile diarrhoea
- Increased risk of bone fractures
- Potential for hypomagnesaemia
Important Disclaimer
The Panflux Otc 20 mg Gastro-resistant tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
